Lushang Freda PharmaceuticalLtd Dividende
Zukünftiges Wachstum Kriterienprüfungen 2/6
Lushang Freda PharmaceuticalLtd is a dividend paying company with a current yield of 1.47% that is well covered by earnings.
Wichtige Informationen
1.5%
Dividendenausschüttung
-0.3%
Rückkaufsrendite
| Gesamte Aktionärsrendite | 1.2% |
| Zukünftige Dividendenrendite | 2.3% |
| Wachstum der Dividende | 5.5% |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | CN¥0.100 |
| Ausschüttungsquote | 63% |
Aktuelle Dividendenentwicklung
Keine Aktualisierungen
Recent updates
Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Doing What It Can To Lift Shares
Jun 21
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?
Apr 16Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations
Mar 28Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 04A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)
Feb 27Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: 600223 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Wachsende Dividende: 600223's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividendenrendite im Vergleich zum Markt
| Lushang Freda PharmaceuticalLtd Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (600223) | 1.5% |
| Untere 25 % des Marktes (CN) | 0.6% |
| Markt Top 25 % (CN) | 2.2% |
| Branchendurchschnitt (Real Estate) | 2.3% |
| Analystenprognose (600223) (bis zu 3 Jahre) | 2.3% |
Bemerkenswerte Dividende: 600223's dividend (1.47%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Hohe Dividende: 600223's dividend (1.47%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: With its reasonable payout ratio (62.8%), 600223's dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: With its high cash payout ratio (179.7%), 600223's dividend payments are not well covered by cash flows.